Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reiko Kaji
Observed names:
Kaji, Reiko,
REIKO KAJI
Institutions:
Kobe Medical Center,
Kurashiki Central Hospital,
Kobe City Medical Center General Hospital,
Foundation for Biomedical Research and Innovation
Observed institutions:
Kyushu University,
Kyoto University,
Kobe Medical Center,
Kurashiki Central Hospital,
Kobe City Medical Center General Hospital,
Foundation for Biomedical Research and Innovation
show all 6
OpenAlex ID:
A5112237591
Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor: Comparison between T790M mutation‐positive and mutation‐negative populations
2013
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Cancer
·
186
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
2016
·
Yoshiko Urata
, Nobuyuki Katakami
, et al.
·
Journal of Clinical Oncology
·
173
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
2015
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Journal of Thoracic Oncology
·
161
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer
2017
·
Shigeki Nanjo
, Akito Hata
, et al.
·
British Journal of Cancer
·
100
PDF
Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer
2010
·
Akito Hata
, Hiroshige Yoshioka
, et al.
·
Journal of Thoracic Oncology
·
99
Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma
2010
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Journal of Thoracic Oncology
·
78
Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
2018
·
Toyoaki Hida
, Reiko Kaji
, et al.
·
Clinical Lung Cancer
·
74
PDF
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?
2012
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Journal of Thoracic Oncology
·
73
PDF
EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma
2015
·
Kosuke Tanaka
, Toyoaki Hida
, et al.
·
Journal of Thoracic Oncology
·
72
PDF
Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection
2011
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Lung Cancer
·
68
High-dose Erlotinib for Refractory Brain Metastases in a Patient with Relapsed Non-small Cell Lung Cancer
2011
·
Akito Hata
, Reiko Kaji
, et al.
·
Journal of Thoracic Oncology
·
53
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation
2013
·
Kosuke Tanaka
, Akito Hata
, et al.
·
Journal of Thoracic Oncology
·
47
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR ‐mutant non–small cell lung cancer: Multicenter, single‐arm, phase 2 trial (ABC Study)
2018
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Cancer
·
44
PDF
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
2015
·
Kyoko Otsuka
, Akito Hata
, et al.
·
Cancer Chemotherapy and Pharmacology
·
44
Programmed death-ligand 1 expression and T790M status in EGFR -mutant non-small cell lung cancer
2017
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Lung Cancer
·
40
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer
2014
·
KATSUHIRO MASAGO
, DAICHI FUJIMOTO
, et al.
·
Molecular and Clinical Oncology
·
39
PDF
An LC-MS/MS Method for Absolute Quantification of Nivolumab in Human Plasma: Application to Clinical Therapeutic Drug Monitoring
2018
·
Kei Irie
, Akira Okada
, et al.
·
Therapeutic Drug Monitoring
·
38
Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer
2014
·
Toshihiko Kaneda
, Akito Hata
, et al.
·
Lung Cancer
·
37
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
2010
·
Shiro Fujita
, Katsuhiro Masago
, et al.
·
BMC Medical Genetics
·
35
PDF
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations
2015
·
Katsuhiro Masago
, Shiro Fujita
, et al.
·
BMC Cancer
·
33
PDF
Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).
2015
·
Tomoyuki Otsuka
, Masahide Mori
, et al.
·
PubMed
·
31
Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.
2015
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
PubMed
·
29
Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non–Small-Cell Lung Cancer
2013
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Journal of Thoracic Oncology
·
23
PDF
Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical blood samples of patients with non-small cell lung cancer
2018
·
Kei Irie
, Saori Shobu
, et al.
·
Journal of Chromatography B
·
20
Multiple Primary Malignancies in Patients with Non-Small Cell Lung Cancer
2015
·
Shiro Fujita
, Katsuhiro Masago
, et al.
·
Internal Medicine
·
19
PDF
Show more works
View as search
Works count:
63
Citation count:
1,824
H-index:
23
I10-index:
35
Year
Topic
Type